Evidence map›Paper›PMID 35603918›Full record

ArticleAddiction (Abingdon, England)2022

The iCannTookit: a consensus-based, flexible framework for measuring contemporary cannabis use.

Valentina Lorenzetti, Chandni Hindocha, Kat Petrilli, Paul Griffiths, Jamie Brown, Álvaro Castillo-Carniglia, Jonathan P Caulkins, Amir Englund, Mahmoud A El Sohly, Suzanne H Gage and 15 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Valentina LorenzettiNeuroscience of Addiction and Mental Health Program, the Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health, Australian Catholic University, Melbourne, Australia.ORCID 0000-0002-5917-7068
Chandni HindochaClinical Psychopharmacology Unit, University College London, London, UK.ORCID 0000-0003-1692-7401
Kat PetrilliAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
Paul GriffithsEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.ORCID 0000-0003-2844-3391
Jamie BrownBehavioural Science and Health Institute of Epidemiology and Health, University College London, London, UK.ORCID 0000-0002-2797-5428
Álvaro Castillo-CarnigliaSociety and Health Research Center and School of Public Health, Universidad Mayor, Chile.
Jonathan P CaulkinsCarnegie Mellon University Heinz College, Pittsburgh, PA, USA.ORCID 0000-0002-7748-9989
Amir EnglundAddictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Mahmoud A El SohlyNational Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA.
Suzanne H GageDepartment of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.ORCID 0000-0002-2368-1115
Teodora GroshkovaEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.
Antoni GualPsychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, RTA, Barcelona, Spain.
David HammondSchool of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.ORCID 0000-0001-8197-6010
Will LawnClinical Psychopharmacology Unit, University College London, London, UK.ORCID 0000-0002-0143-2724
Hugo López-PelayoPsychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, RTA, Barcelona, Spain.
Jakob MantheyInstitute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
Claire MokryszClinical Psychopharmacology Unit, University College London, London, UK.ORCID 0000-0002-1970-8530
Rosalie Liccardo PaculaUSC Sol Price School of Public Policy, USC Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA.
Margriet van LaarTrimbos Institute, Utrecht, the Netherlands.ORCID 0000-0003-3977-126X
Ryan VandreyDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Elle WadsworthSchool of Public Health Sciences, University of Waterloo, Waterloo, ON, Canada.ORCID 0000-0003-0797-8493
Adam WinstockBehavioural Science and Health Institute of Epidemiology and Health, University College London, London, UK.
Wayne HallNational Addiction Centre, King's College London, London, UK.ORCID 0000-0003-1984-0096
H Valerie CurranClinical Psychopharmacology Unit, University College London, London, UK.
Tom P FreemanAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.ORCID 0000-0002-5667-507X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabisHallucinogensAnalgesicsCannabinoid Receptor AgonistsConsensusHumansAnalgesicsCannabinoid Receptor AgonistsHallucinogensAssessmentcannabisdosemeasurementstandardizationtoolkit

Identifiers

PMID35603918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.